HIV and AIDS Trial, Recruiting (NCT07329166)

HIV and AIDS Trial, Recruiting NCT07329166 Sponsor: University of California, Los Angeles Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT07329166 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 15 years of age or older
People who are living with HIV
People who are attending an ART (HIV treatment) clinic to start HIV treatment for the very first time
People who are attending an ART clinic to restart HIV treatment after missing a refill appointment by more than 28 days

Who may not be able to join:

People who are attending the ART clinic on behalf of someone else, such as a guardian picking up medication for another person
People who are attending the ART clinic only to collect an emergency refill
People who are attending the ART clinic for a routine refill and have not had a gap in treatment of 28 days or more
People who are transferring to the study clinic from another clinic and have not had a gap in their treatment of 28 days or more

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (310) 267-5844

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07329166

Sponsor: University of California, Los Angeles

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: (310) 267-5844

More information: https://clinicaltrials.gov/study/NCT07329166

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 15 years of age or older
People who are living with HIV
People who are attending an ART (HIV treatment) clinic to start HIV treatment for the very first time
People who are attending an ART clinic to restart HIV treatment after missing a refill appointment by more than 28 days

Who may not be able to join:

People who are attending the ART clinic on behalf of someone else, such as a guardian picking up medication for another person
People who are attending the ART clinic only to collect an emergency refill
People who are attending the ART clinic for a routine refill and have not had a gap in treatment of 28 days or more
People who are transferring to the study clinic from another clinic and have not had a gap in their treatment of 28 days or more

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, Los Angeles

Registry

ClinicalTrials.gov

Start date

18 December 2025

Est. completion

1 February 2027

Where this trial is recruiting

Malawi

Primary endpoints

Acceptability of REMIT intervention package; Feasibility of REMIT intervention package

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov